Duke University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Duke University sits in the top decile of US sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count).
Duke University: 1,725 sponsored US clinical trials, 187 recruiting.
Duke University sponsors 1,725 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 1,244 completed. 175 of these trials are in Phase 3-4 (later-stage) and 311 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
Duke University ranks in the top decile of sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,244 of 1,444 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,725 total, page 24 of 35
Self-Reported Exercise Behavior and Short-Term Patient Outcomes in Women Undergoing Radiation Treatment for Operable Breast Cancer
NCT02050620
Thoracoabdominal Arortic CTA Study
NCT02291718
Ammonia Levels and Cognitive Impairment
NCT02059356
Negative Pressure Wound Therapy to Reduce Surgical Site Infection
NCT01905397
Carbohydrate Restriction and Prostate Cancer Growth
NCT01763944
Development of Novel Therapies for NIDDM
NCT01905722
Effects of Ranolazine and Exercise on Daily Physical Activity Trial
NCT01948310
Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD
NCT01990079
Pancreatic Resection, Malnutrition and Readmission
NCT01947166
Valproic Acid for the Prevention of Post-Amputation Pain
NCT01928849
Comparison Study of Transversus Abdominal Plane, Paravertebral and Epidural Blocks in Laparoscopic Colectomy
NCT02164929
GM03 - Platelet RNA Signatures of Aspirin
NCT05278637
Patient-centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research
NCT02146274
Medication Therapy Management With Pharmacogenetic Testing
NCT01970774
A Pilot Study of Ipilumimab and Radiation in Poor Prognosis Melanoma
NCT01996202
Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer
NCT01890213
Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care
NCT01993836
mPCST for BMT Patients
NCT01984671
Improving Adherence to Recommended Surveillance in Breast Cancer Survivors
NCT02189278
Advancing the Standard of Care for Pin Site Care
NCT01965665
Lymphedema in Endometrial Cancer
NCT01914276
Clinical Immunization Safety Assessment (CISA) Project: Pilot Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After IIV
NCT01946594
Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer
NCT01940276
PVI for Prediction of Spinal Induced Hypotension
NCT01967914
Improving Psychological Distress Among Critical Illness Survivors and Their Caregivers
NCT01983254
Epidural Analgesia Versus IV Analgesia in Lumbar Spine Fusions
NCT01986946
Socio-Economic Survey in Uganda
NCT01971697
Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease
NCT01937221
Feasibility of Blood Oxygenation Level-Dependent Contrast (BOLD) Breast MRI Induced by Breath- Holding
NCT01898533
The Effect of Scheduled Ripcord Removal on the Outcomes of Baerveldt 350 Implants
NCT01915706
Automated MEdical Record Driven Implantable CArdioverter-defibrillator Heart Failure Trial (AMERICA-HF)
NCT01807130
Screening, Brief Intervention, and Referral to Treatment in Primary Care
NCT01966432
Third Ventriculostomy Versus Shunt for Children With Hydrocephalus
NCT01801267
The Early Truancy Prevention Project
NCT01894464
Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant
NCT01904175
Quantifying the Presence of Lung Disease and Pulmonary Hypertension in Children With Sickle Cell Disease
NCT01895998
Triadic Expectations: Decision Making in the Context of Cancer Treatment
NCT01898481
The Effect of Prophylactic FFP Administration on ECMO Circuit Longevity
NCT01903863
Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease
NCT01884545
Therapeutic Plasma Exchange in MG
NCT01927692
Genetically Guided Statin Therapy
NCT01894230
Comparison of Transbronchial, Cryoprobe and VATS Biopsy For the Diagnosis of Interstitial Lung Disease (ILD)
NCT01972685
New Media Obesity Treatment in Community Health Centers
NCT01827800
Effect of CPAP on Postoperative Delirium
NCT01816685
Freezing of Gait in Parkinson's Disease
NCT01887054
Safety and Efficacy of Albuterol in Individuals With Late-onset Pompe Disease
NCT01885936
ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients
NCT01867047
Longitudinal Assessment of Cardiovascular and Renal Health in Patients With Hepatitis-C (CARE-Hep C)
NCT01846494
Bone Metabolism After Bariatric Surgery
NCT01824797
Comparative Effectiveness of Rehabilitation Services for Survivors of Acute Ischemic Stroke
NCT02284165
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 136 |
| Phase 2 | 175 |
| Phase 3 | 41 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Duke University pipeline
187 recruiting of 1,725 indexed (11% open); 1,244 completed (72%).
Phase mix: 175 late (III/IV) vs 311 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Duke University: open-pipeline peers nationwide
Peers matched on 1,725 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Duke University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,725 trials (± recruiting share)
- University of California, San Francisco · 1,713 trials · 16% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 11% open enrollment (± trial volume)
- Carnegie Mellon University · 11% recruiting · 37 trials
- CAMC Health System · 11% recruiting · 28 trials
- UConn Health · 11% recruiting · 178 trials
- Hartford Hospital · 11% recruiting · 75 trials
Related
What to do with this Duke University page
1,725 registered trials is a research-attention snapshot, not an endorsement of Duke University or any single study.
- 187 of Duke University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Duke University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Duke University pipeline card: 1,725 registered trials from official public datasets.Report a data error.